ArticleFrontiers in oncology2021

The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation.

Chang Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.